PATRICK J. ABBOTT, M.D.

Department of
Psychiatry

PROFESSOR, DEPARTMENT OF PSYCHIATRY
MEDICAL DIRECTOR, ALCOHOL AND SUBSTANCE ABUSE PROGRAM
MEDICAL DIRECTOR/CONSULTANT, MILAGRO PROGRAM
CONSULTANT, TRUMAN STREET CLINIC

M.D., University of Nebraska, 1973
Residency, University of New Mexico, 1977-80

Email: pabbott@salud.unm.edu
 

Areas of Specialization: Treatment of substance abuse; methadone and buprenorphine assisted treatment; treatment of alcoholism in the American Indian community; cross cultural psychiatry; comorbid psychiatry disorder in substance abusers, epidemiology and treatment

Recent Publications:

Bogenschutz MP,Abbott PJ, Kushner R, Tonigan S, & Woody GE (2010). Effects of buprenorphine and hepatitis on liver enzymes in adolescents and young adults.Journal of Addiction Medicine , 4 (4): 211-216.

Abbott PJ. (2010). Case Management: Ongoing Evaluation of Patients’ Needs in an Opioid Treatment Program, Professional Case Management,
15(3): 145-152.

Abbott PJ (2009). A review of the community reinforcement approach in the treatment of opioid dependence. Journal of Psychoactive Drugs,
Dec; 41(4): 379-85.

Woody GE, Poole S, Subramaniam G, Dugosh K, Bogenschutz M, Abbott PJ, Patkar A, Publicker M, McCain K, Sharpe Potter J, Forman R, Vetter V, McNicholas L, Blaine J, Lynch K, & Fudala PJ. (November 2008) “Outpatient Treatment of Opioid Addicted 15-21Year Olds Using Buprenorphine and Counseling: Better Outcomes by Continuing Medication”. JAMA, Vol. 300(17), 2003-2011.

Abbott PJ, Chase D (January 2008). Culture and Substance Abuse, Impact of Culture Affects Approach to Treatment. Psychiatric Times, January Vol. 24 (1), 43-46.

Abbott PJ (2006). Co-morbid alcohol/other drug abuse/dependence and psychiatric disorders in adolescent American Indian and Alaska Natives. Alcoholism Treatment Quarterly 24(4), 3-21.

Recent Presentations:

“Update on Opioid Treatment”, Department Conference Series – Grand Rounds, University of New Mexico,       School of Medicine, Department of Psychiatry. Albuquerque New Mexico, March 14, 2008.

 “Methamphetamine Abuse in New Mexico”, Albuquerque Chamber of Commerce, Leadership Albuquerque       Program’s Law and Order Day, March 5, 2008.

“Pharmacology of Opioids and Buprenorphine”. Buprenorphine Training Course. February 9, 2007.

“Special populations”. Buprenorphine Training Course. February 9. 2007.

“Pharmacology of Buprenorphine”.  Buprenorphine Training Course. September 22, 2006

“Special populations/Co-occurring disorders”. Buprenorphine Training Course. September 22, 2006

Recent Grants:

Abbott PJ, LoPorto J, Harris M, Motivational Incentives in Substance Abuse, ValueOptions, June 2008 - July 2009.

Woody G, Buprenorphine/naloxone facilitated rehabilitation for opioid dependent adolescents/young adults, sub-investigator NIDA Clinical Trials Net work (2003-2005). 

Abbott PJ, Baca C, Westerberg V, & Tonigan S (1999-2003).  Opiate Treatment Enhancement Project.  Center for Substance Abuse Treatment (CSAT), Targeted Capacity Expansion Grant No.1 H79 TI11963-01.